Deutsch English Français

Contact

EP1175218

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1175218

EP1175218 - OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-BETA [Right-click to bookmark this link]
Status	The application has been refused Status updated on 13.05.2011 Database last updated on 18.05.2024
Most recent event Tooltip	13.05.2011	Change - refusal	published on 15.06.2011 [2011/24]
Applicant(s)	For all designated states THE SCHEPENS EYE RESEARCH INSTITUTE, INC. 20 Staniford Street Boston, MA 02114 / US
	[2002/05]
Inventor(s)	01 / SULLIVAN, David, A. 120 Fulton Street, No 203 Boston, MA 02109 / US
	[2002/10]
Former [2002/05]	01 / SULLIVAN, David, A. 507 Main Street Acton, MA 01720 / US
Representative(s)	Portal, Gérard, et al Cabinet Beau de Loménie 158, rue de l'Université 75340 Paris Cedex 07 / FR
	[N/P]
Former [2002/05]	Portal, Gérard, et al Cabinet Beau de Loménie 158, rue de l'Université 75340 Paris Cédex 07 / FR
Application number, filing date	00917961.5	15.03.2000
	[2002/05]
	WO2000US06787
Priority number, date	US19990271600	17.03.1999 Original published format: US 271600
	[2002/05]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0054779
	Date:	21.09.2000
	Language:	EN
	[2000/38]
	Type:	A1 Application with search report
	No.:	EP1175218
	Date:	30.01.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 21.09.2000 takes the place of the publication of the European patent application.
	[2002/05]
Search report(s)	International search report - published on:	US	21.09.2000
	(Supplementary) European search report - dispatched on:	EP	08.11.2005
Classification	IPC:	A61K31/56, A61K31/568, A61P27/02	[2005/51]
	CPC:	A61K31/56 (EP,US); A61K31/568 (EP,US); A61K9/0048 (EP,US); A61P27/02 (EP)
	Former IPC [2002/05]	A61K31/56
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/05]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	AUGENTHERAPIE DER KERATOCONJUNCTIVITIS SICCA DURCH TOPISCHE ANWENDUNG VON ANDROGENEN UND TGF-BETA	[2002/05]
	English:	OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-BETA	[2002/05]
	French:	THERAPIE OCULAIRE POUR LA KERATOCONJONCTIVITE SECHE BASEE SUR L'APPLICATION LOCALE D'ANDROGENES OU DE TGF-BETA	[2002/05]
Entry into regional phase	16.10.2001	National basic fee paid
	16.10.2001	Search fee paid
	16.10.2001	Designation fee(s) paid
	16.10.2001	Examination fee paid
Examination procedure	13.10.2000	Request for preliminary examination filed International Preliminary Examining Authority: US
	17.10.2001	Examination requested [2002/05]
	27.01.2006	Amendment by applicant (claims and/or description)
	28.03.2006	Despatch of a communication from the examining division (Time limit: M06)
	26.09.2006	Reply to a communication from the examining division
	15.05.2007	Despatch of a communication from the examining division (Time limit: M04)
	18.09.2007	Reply to a communication from the examining division
	08.04.2008	Application refused, date of legal effect [2008/24]
	08.04.2008	Date of oral proceedings
	08.05.2008	Despatch of communication that the application is refused, reason: substantive examination [2008/24]
	08.05.2008	Despatch of communication that the application is refused, reason: substantive examination [2011/24]
	08.05.2008	Minutes of oral proceedings despatched
	18.05.2008	Application refused, date of legal effect [2011/24]
Fees paid	Renewal fee
	21.03.2002	Renewal fee patent year 03
	26.03.2003	Renewal fee patent year 04
	15.03.2004	Renewal fee patent year 05
	12.05.2005	Renewal fee patent year 06
	09.03.2006	Renewal fee patent year 07
	14.03.2007	Renewal fee patent year 08
	Penalty fee
	Additional fee for renewal fee
	31.03.2005	06 M06 Fee paid on 12.05.2005
	31.03.2008	09 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[DY]US4617299 (KNEPPER PAUL A [US]) [DY] 39* column 7, paragraph 2 *;
		[XY]WO9320823 (SCHEPEN S EYE RESEARCH INST IN [US]) [X] 1-38 * the whole document * [Y] 39;
		[XY]WO9640183 (SCHEPENS EYE RES INST [US]) [X] 1-38 * the whole document * [Y] 39;
		[A] - VENDRAMINI A C L M ET AL, "Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjogren's syndrome", INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE 1991 UNITED STATES, (1991), vol. 32, no. 11, ISSN 0146-0404, pages 3002 - 3006, XP002351077 [A] 1-39 * page 3002 *
		[A] - STERN M E ET AL, "THE PATHOLOGY OF DRY EYE: THE INTERACTION BETWEEN THE OCULAR SURFACE AND LACRIMAL GLANDS", CORNEA, MASSON PUBL., NEW YORK, NY, US, (199811), vol. 17, no. 6, ISSN 0277-3740, pages 584 - 589, XP009010472 [A] 1-39 * abstract * DOI: http://dx.doi.org/10.1097/00003226-199811000-00002
	International search	[A]US4863912 (SOUTHREN AARON L [US], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p